Publications by authors named "M Eugenia Fernandez-Santos"

Background: Despite tremendous therapeutic advancements, a significant proportion of coronary artery disease patients suffer from refractory angina pectoris, that is, quality-of-life-compromising angina that is non-manageable with established pharmacological and interventional treatment options. Adenoviral vascular endothelial growth factor-D (AdVEGF-D)-encoding gene therapy (GT) holds promise for the treatment of refractory angina.

Methods: ReGenHeart is an investigator-initiated, multicentre, randomised, placebo-controlled and double-blinded phase 2 clinical trial that aims to study the safety and efficacy of intramyocardially administered angiogenic AdVEGF-D GT for refractory angina.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers are exploring new ways to enhance interactions between cells and the extracellular matrix (ECM) to improve kidney organoid development from human pluripotent stem cells (hPSCs).
  • They created renal decellularized ECM (dECM) hydrogels from porcine and human kidney tissue, which support more effective kidney differentiation and the formation of blood vessel features in organoids.
  • This study establishes a method to generate kidney organoids with vascular-like structures, demonstrating the potential for these improved culture systems in advancing personalized medicine applications.
View Article and Find Full Text PDF

Due to their suppressive capacity, regulatory T cells (Tregs) have attracted growing interest as an adoptive cellular therapy for the prevention of allograft rejection, but limited Treg recovery and lower quality of adult-derived Tregs could represent an obstacle to success. To address this challenge, we developed a new approach that provides large quantities of Tregs with high purity and excellent features, sourced from thymic tissue routinely removed during pediatric cardiac surgeries (thyTregs). We report on a 2-year follow-up of the first patient treated worldwide with thyTregs, included in a phase I/II clinical trial evaluating the administration of autologous thyTreg in infants undergoing heart transplantation.

View Article and Find Full Text PDF

Male infertility (MI) involves various endogenous and exogenous facts. These include oxidative stress (OS), which is known to alter several physiological pathways and it is estimated to be present at high levels in up to 80% of infertile men. That is why since the late 20th century, the relationship between OS and MI has been widely studied.

View Article and Find Full Text PDF